Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Death begets failure in the heart.

Roger S-Y Foo1, Kartik Mani, Richard N Kitsis

  • 1Department of Medicine, Cardiovascular Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

The Journal of Clinical Investigation
|March 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thromboxane receptor activation in dendritic cells mitigates sepsis by suppressing S100a8/a9-mediated neutrophil recruitment.

Signal transduction and targeted therapy·2026
Same author

<i>CLIPPER</i> Regulates LPIN1-Mediated Mitochondrial Biogenesis and Heart Regeneration.

Circulation research·2026
Same author

Ferroptosis in heart failure: from molecular insights to therapeutic implications.

Cardiovascular research·2026
Same author

Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy.

Science (New York, N.Y.)·2026
Same author

Regulated Cell Death in Myocardial Infarction.

Circulation research·2025
Same author

Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.

Circulation·2025
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Abnormal cardiomyocyte apoptosis, a form of cell death, is linked to heart failure. Research in rodent models suggests this cell death plays a causal role, offering potential therapeutic targets for heart failure.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathology

Background:

  • Recent observations indicate low, yet abnormal, rates of cardiomyocyte apoptosis in failing human hearts.
  • Cardiomyocyte apoptosis has been implicated as a contributing factor in the progression of heart failure.

Purpose of the Study:

  • To review existing data on the role of cardiomyocyte apoptosis in heart failure.
  • To discuss the potential therapeutic implications of targeting cardiomyocyte apoptosis.

Main Methods:

  • Review of genetic studies in rodent models.
  • Review of pharmacological studies in rodent models.
  • Synthesis of current evidence linking cardiomyocyte apoptosis to heart failure.

Main Results:

Related Experiment Videos

  • Genetic and pharmacological studies in rodent models suggest a causal link between cardiomyocyte apoptosis and heart failure.
  • These findings highlight the significance of cardiomyocyte cell death in the pathophysiology of heart failure.

Conclusions:

  • Cardiomyocyte apoptosis is a relevant factor in heart failure, supported by evidence from genetic and pharmacological studies.
  • Targeting cardiomyocyte apoptosis presents a potential therapeutic strategy for managing heart failure.